ECI
EFG Capital International Portfolio holdings
AUM
$432M
1 Year Est. Return
–
AUM
$432M
AUM Growth
–
Holding
138
Top Buys
| 1 | +$23.8M | |
| 2 | +$15.8M | |
| 3 | +$15.3M | |
| 4 |
Amazon
AMZN
|
+$12.6M |
| 5 |
Mastercard
MA
|
+$12.1M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Technology | 23.44% |
| 2 | Healthcare | 13.36% |
| 3 | Financials | 10.55% |
| 4 | Consumer Discretionary | 9.75% |
| 5 | Industrials | 7.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Neurocrine Biosciences
NBIX
$14.2B
| $296K | 0.07% |
+3,140
|
|
||
127
Halozyme
HALO
$7.74B
| $289K | 0.07% |
+8,009
|
|
||
128
Exact Sciences
EXAS
$12.7B
| $287K | 0.07% |
+3,053
|
|
||
129
iShares Gold Trust
IAU
$61B
| $280K | 0.06% |
+7,678
|
|
||
130
Vanguard S&P 500 Value ETF
VOOV
$5.77B
| $279K | 0.06% |
+1,794
|
|
||
131
SPDR S&P 500 ETF Trust
SPY
$679B
| $273K | 0.06% |
+616
|
|
||
132
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.28B
| $263K | 0.06% |
+6,348
|
|
||
133
Doximity
DOCS
$12.5B
| $242K | 0.06% |
+7,125
|
|
||
134
Rocket Pharmaceuticals
RCKT
$384M
| $233K | 0.05% |
+11,711
|
|
||
135
Mondelez International
MDLZ
$73.1B
| $232K | 0.05% |
+3,185
|
|
||
136
Sarepta Therapeutics
SRPT
$2.56B
| $231K | 0.05% |
+2,020
|
|
||
137
Charles River Laboratories
CRL
$8.8B
| $230K | 0.05% |
+1,092
|
|
||
138
Invesco S&P 500 Equal Weight ETF
RSP
$73.8B
| $211K | 0.05% |
+1,412
|
|